Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 1990 Mar;36:487-490, 499.

L'arthrite rhumatoide: approche thérapeutique

Charlotte Grondin
PMCID: PMC2280671  PMID: 21234065

Abstract

Rheumatoid arthritis is the most common chronic inflammatory joint disease. To overcome joint inflammation and eventually induce disease remission, the physician must often use drugs that are more and more toxic. Indications, method of administration, and common adverse effects of non-steroidal anti-inflammatory drugs, local steroid injections, second-line agents, and steroids are reviewed. The author briefly discusses a new therapeutic concept and emphasizes the importance of patient education and early referral to an interdisciplinary rehabilitation team.

Keywords: anti-inflammatoires non-stéroïdiens, arthrite rhumatoïde, corticostéroïdes, immunosuppresseurs, réadaptation fonctionnelle

Full text

PDF
487

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abramson S. B., Weissmann G. The mechanisms of action of nonsteroidal antiinflammatory drugs. Arthritis Rheum. 1989 Jan;32(1):1–9. doi: 10.1002/anr.1780320102. [DOI] [PubMed] [Google Scholar]
  2. Amor B., Herson D., Cherot A., Delbarre F. Polyarthrites rhumatoïdes évoluant depuis plus de 10 ans (1966-1978). Analyse de l'évolution et des traitements de 100 cas. Ann Med Interne (Paris) 1981;132(3):168–173. [PubMed] [Google Scholar]
  3. Belch J. J., Ansell D., Madhok R., O'Dowd A., Sturrock R. D. Effects of altering dietary essential fatty acids on requirements for non-steroidal anti-inflammatory drugs in patients with rheumatoid arthritis: a double blind placebo controlled study. Ann Rheum Dis. 1988 Feb;47(2):96–104. doi: 10.1136/ard.47.2.96. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brick J. E., Moreland L. W., Al-Kawas F., Chang W. W., Layne R. D., DiBartolomeo A. G. Prospective analysis of liver biopsies before and after methotrexate therapy in rheumatoid patients. Semin Arthritis Rheum. 1989 Aug;19(1):31–44. doi: 10.1016/0049-0172(89)90085-1. [DOI] [PubMed] [Google Scholar]
  5. Brook A., Corbett M. Radiographic changes in early rheumatoid disease. Ann Rheum Dis. 1977 Feb;36(1):71–73. doi: 10.1136/ard.36.1.71. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Caughey D. E. Patient communication and effective rheumatology. J Rheumatol. 1989 Jan;16(1):5–6. [PubMed] [Google Scholar]
  7. Champion G. D., Cairns D. R., Bieri D., Adena M. A., Browne C. D., Cohen M. L., Day R. O., Edmonds J. P., Graham G. G., de Jager J. Dose response studies and longterm evaluation of auranofin in rheumatoid arthritis. J Rheumatol. 1988 Jan;15(1):28–34. [PubMed] [Google Scholar]
  8. Ciabattoni G., Cinotti G. A., Pierucci A., Simonetti B. M., Manzi M., Pugliese F., Barsotti P., Pecci G., Taggi F., Patrono C. Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin. N Engl J Med. 1984 Feb 2;310(5):279–283. doi: 10.1056/NEJM198402023100502. [DOI] [PubMed] [Google Scholar]
  9. Clements P. J., Davis J. Cytotoxic drugs: their clinical application to the rheumatic diseases. Semin Arthritis Rheum. 1986 May;15(4):231–254. doi: 10.1016/0049-0172(86)90020-x. [DOI] [PubMed] [Google Scholar]
  10. Clinch D. Why not have definitive trials of gastrointestinal safety for non-steroidal anti-inflammatory drugs? Discussion paper. J R Soc Med. 1988 Mar;81(3):158–160. doi: 10.1177/014107688808100313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Decker J. L. Azathioprine and cyclophosphamide as slow-acting drugs for rheumatoid arthritis. Am J Med. 1983 Dec 30;75(6A):74–78. doi: 10.1016/0002-9343(83)90478-3. [DOI] [PubMed] [Google Scholar]
  12. Docken W. P. Low-dose prednisone therapy. Rheum Dis Clin North Am. 1989 Aug;15(3):569–576. [PubMed] [Google Scholar]
  13. Graham G. G. Pharmacokinetics and metabolism of non-steroidal anti-inflammatory drugs. Med J Aust. 1987 Dec 7;147(11-12):597–602. [PubMed] [Google Scholar]
  14. Gray R. G., Gottlieb N. L. Intra-articular corticosteroids. An updated assessment. Clin Orthop Relat Res. 1983 Jul-Aug;(177):235–263. [PubMed] [Google Scholar]
  15. Gray R. G., Tenenbaum J., Gottlieb N. L. Local corticosteroid injection treatment in rheumatic disorders. Semin Arthritis Rheum. 1981 May;10(4):231–254. doi: 10.1016/0049-0172(81)90001-9. [DOI] [PubMed] [Google Scholar]
  16. Klipple G. L., Cecere F. A. Rheumatoid arthritis and pregnancy. Rheum Dis Clin North Am. 1989 May;15(2):213–239. [PubMed] [Google Scholar]
  17. Kushner I. Does aggressive therapy of rheumatoid arthritis affect outcome? J Rheumatol. 1989 Jan;16(1):1–4. [PubMed] [Google Scholar]
  18. Lee P. Anti-inflammatory therapy during pregnancy and lactation. Clin Invest Med. 1985;8(4):328–332. [PubMed] [Google Scholar]
  19. Maguire J. H. Advances in the control of perioperative sepsis in total joint replacement. Rheum Dis Clin North Am. 1988 Dec;14(3):519–535. [PubMed] [Google Scholar]
  20. Maksymowych W., Russell A. S. Antimalarials in rheumatology: efficacy and safety. Semin Arthritis Rheum. 1987 Feb;16(3):206–221. doi: 10.1016/0049-0172(87)90023-0. [DOI] [PubMed] [Google Scholar]
  21. McCune W. J., Bayliss G. E. Immunosuppressive drug therapy. Curr Opin Rheumatol. 1989 Jun;1(1):80–88. doi: 10.1097/00002281-198901010-00016. [DOI] [PubMed] [Google Scholar]
  22. Mills J. A., Pinals R. S., Ropes M. W., Short C. L., Sutcliffe J. Value of bed rest in patients with rheumatoid arthritis. N Engl J Med. 1971 Mar 4;284(9):453–458. doi: 10.1056/NEJM197103042840901. [DOI] [PubMed] [Google Scholar]
  23. Moens H. J., Ament B. J., Feltkamp B. W., van der Korst J. K. Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens. J Rheumatol. 1987 Dec;14(6):1115–1119. [PubMed] [Google Scholar]
  24. Ostensen M., Husby G. Antirheumatic drug treatment during pregnancy and lactation. Scand J Rheumatol. 1985;14(1):1–7. doi: 10.3109/03009748509102008. [DOI] [PubMed] [Google Scholar]
  25. Pinals R. S. Sulfasalazine in the rheumatic disease. Semin Arthritis Rheum. 1988 May;17(4):246–259. doi: 10.1016/0049-0172(88)90010-8. [DOI] [PubMed] [Google Scholar]
  26. Schlegel S. I., Paulus H. E. Non-steroidal and analgesic therapy in the elderly. Clin Rheum Dis. 1986 Apr;12(1):245–273. [PubMed] [Google Scholar]
  27. Scott D. L., Symmons D. P., Coulton B. L., Popert A. J. Long-term outcome of treating rheumatoid arthritis: results after 20 years. Lancet. 1987 May 16;1(8542):1108–1111. doi: 10.1016/s0140-6736(87)91672-2. [DOI] [PubMed] [Google Scholar]
  28. Simon L. S. Toxicity of nonsteroidal anti-inflammatory drugs. Curr Opin Rheumatol. 1989 Jun;1(1):68–73. doi: 10.1097/00002281-198901010-00014. [DOI] [PubMed] [Google Scholar]
  29. Spiegel J. S., Spiegel T. M., Ward N. B. Are rehabilitation programs for rheumatoid arthritis patients effective? Semin Arthritis Rheum. 1987 May;16(4):260–270. doi: 10.1016/0049-0172(87)90004-7. [DOI] [PubMed] [Google Scholar]
  30. Van den Ouweland F. A., Gribnau F. W., Meyboom R. H. Congestive heart failure due to nonsteroidal anti-inflammatory drugs in the elderly. Age Ageing. 1988 Jan;17(1):8–16. doi: 10.1093/ageing/17.1.8. [DOI] [PubMed] [Google Scholar]
  31. Weiss M. M. Corticosteroids in rheumatoid arthritis. Semin Arthritis Rheum. 1989 Aug;19(1):9–21. doi: 10.1016/0049-0172(89)90083-8. [DOI] [PubMed] [Google Scholar]
  32. Wilske K. R., Healey L. A. Remodeling the pyramid--a concept whose time has come. J Rheumatol. 1989 May;16(5):565–567. [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES